Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

RCPSC > Respirology > Flashcards

Respirology Flashcards

1
Q

Name the 2 criteria needed for a diagnosis of asthma

A
  1. History of Variable respiratory symptoms that vary over time and intensity
  2. Confirmed Variable expiratory airflow limitation
    1. Need spirometry for diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name 4 clinical phenotypes of asthma

A
  1. Allergic: Classic asthma, atopy, eosinophilic inflammation, responds to ICS
  2. Non-allergic: Neutrophilic, eosinophilic or paucigranulocytic inflammation with less response to. ICS
  3. Adult-onset: Non-allergic, requires higher ICS doses, rule-out occupational asthma
  4. Asthma associated with obesity: little eosinophilic inflammation
  5. Associated with persistent airflow limitation: Longstanding asthma causing fixed obstrucion due to airway remodelling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is asthma diagnosed

A
  • On PFT. Require presence of 2 criteria
    1. Expiratory airflow limitation
      1. Reduced FEV1/FVC confirmed at least once
    2. Variability, demonstrated by presence of at least one of the following:
      1. Positive bronchodilator reversibility
        1. Improvement in FEV1 by >12% and 200ml post bronchodilator
      2. Improvement in lung function with antiinflammatory treatments x4 weeks
        1. Improvement in FEV1>12% and 200ml
      3. Peak flow variability
        1. Average daily diurnal PEF variability >10%
        2. Excessive variability in twice daily PEF over 2 weeks
      4. Positive bronchial challenge test or exercise challenge test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the criteria for a positive, borderline and negative methacholine challenge

A
  • Look for drop in FEV1 by 20% while giving increasing doses of metacholine. The dose required is your PC20
    • PC20 < 4 mg/ml = positive
    • PC20 4-16 = borderline
    • PC20 > 16 = negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What criteria makes an exercise challenge positive for asthma

A

Fall in FEV1 of > 10% and 200ml from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the CTS asthma control criteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List risk factors for severe asthma exacerbation

A
  1. Any history of a previous severe asthma exacerbation
  2. poorly controlled asthma as per CTS criteria
  3. Current smoker
  4. Overuse of SABA (= use of more than 2 saba inhalers per year)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What defines a severe asthma exacerbation

A
  • Any one of
    1. Requires systemic steroids
    2. Requires ED visit
    3. Requires hospital admission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the stepwise approach to asthma as per the GINA guidelines

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the non-pharmacological treatments for asthma

A
  1. confirm the diagnosis, education and written asthma action plan
  2. Weight loss, exercise training
  3. Allergen/trigger avoidance. allergen immunotherapy
  4. Smoking cessation
  5. vaccination
  6. Avoidance of NSAIDS +/- Beta-blockers
  7. Treat comorbidities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should be assessed before stepping up asthma therapy

A
  1. Inhaler technique and adherence
  2. optimisation of non-pharmacological management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When can you consider stepping down asthma therapy

A

If patient has symptom control for 2 months and is low risk for exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should LTRA be considered in asthma

A

Less effective than inhalers

May be appropriate as initial controller therapy in patients who are intolerant or unwilling to use ICS

Most effective in aspirin induced asthma, exercise induced asthma or allergic rhinitis

LABA-ICS > ICS-LTRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What black box warning is associated with Montelukast

A

Increased suicidality in adolescents and adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between uncontrolled and severe asthma

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What workup should be sent in severe asthma

A
  1. Total IgE
  2. Peripheral eosinophil count
  3. Sputum eosinophils and FeNO when available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What classes of medications can be considered in severe asthma

A
  1. Tiotropium mist inhaler
  2. Macrolides
  3. Biologics
  4. Low dose oral corticosteroids
  5. ?Bronchial thermoplasty in specialized centers
    1. Role remains uncleat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Omalizumab and what are the indications for it’s use?

A

Anti-IgE

  1. Indication
    1. Allergic asthma with IgE 30-700 sensitive to at least 1 perennial allergen, severe despite high doses ACS and one other controller
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are mepolizumab, resilizumab and benralizumab and what are their indications

A

Anti IL-5

  1. Indications
    1. Severe eosinophilic asthma (Eos >300) and recurrent exacerbations despite high dose ICS and another controller
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is dupilumab and what are it’s indications?

A

Anti IL-4 and IL-13

  1. Add-on option for severe eosinophilic asthma or those with nasal polyposis moderate-severe atopic dermatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is seasonal allergic asthma treated

A

Start ICS immediately when symptoms commence and continue for 4 weeks after relevant pollen season ends

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is exercise-induced asthma treated

A

Salbutamol pre-exercise

if insufficient add LTRA pre-exercise

If still insufficient try regular ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What percent of patients with asthma will have worstening of their asthma symptoms during pregnancy

A
  • Rule of thirds:
    • 1/3 get better
    • 1/3 stay the same
    • 1/3 get worst
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

In which trimester of pregnancy are asthma exacerbations most common

A

second trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Having asthma increases your risk for these 3 conditions during pregnancy

A
  1. Pre-eclampsia
  2. Low birth weight
  3. pre-term birth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How is asthma treated during pregnancy?

A

The same as outside of pregnancy

*Budesonide is the ICS with the best evidence for safety in pregnancy but all ICS are likely safe

Do NOT withhold oral steroids if a patient is exacerbating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the specific triad associated with ASA exacerbated respiratory disease?

A
  1. Asthma
  2. nasal polyps
  3. ASA/NSAIDs sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How is ASA exacerbated respiratory disease treated?

A
  • Avoid NSAIDS/ASA
  • Can treat like normal asthma but good response to LTRA
  • ASA desensitization can be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Name 5 asthma plus syndromes/asthma mimics

A
  1. Bronchiectasis
  2. EGPA
  3. Vocal cord dysfunction
  4. ABPA
  5. reactive airways dysfunction syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the symptoms of EGPA

A
  1. Asthma
  2. Eosinophilia
  3. granulomatous vasculitis:
    1. Cardiac
    2. Sinusitis
    3. allergic rhinitis
    4. transient pulmonary infiltrates
    5. purpura
    6. neuro
    7. GI
  4. 30-60% have positive p-ANCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the symptoms of vocal cord dysfunction

A
  • Sx:
    • Abrupt onset inspiratory stridor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How is vocal cord dysfunction diagnosed?

A

Via laryngoscopy (adduction of vocal cords on inspiration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How is vocal cord dysfunction treated

A

Speech therapy

*also education, behavior modification, and treating possible underlying GERD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the symptoms of ABPA

A
  1. Can complicate asthma
  2. Presents with recurrent exacerbations with:
    1. Fever
    2. brown sputum with “casts”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the diagnostic criteria for ABPA?

A
  1. Asthma
  2. pulmonary infiltrates
  3. Skin and serum precipitins to aspergillus
  4. Increased total IgE and aspergillus specific IgE >1000
  5. Increased eosinophils
  6. Central bronchiectasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How is ABPA treated?

A
  • Corticosteroids (cornerstone of Tx)
  • Itraconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Describe the symptoms of reactive airway dysfunction syndrome

A

Acute form of irritant induced asthma with symptoms promptly following a single high dose exposure to vapors, gasses or fumes

Lasts > 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How is reactive airways dysfunction syndrome treated

A

Same way as asthma exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is the spirometry diagnosis criteria for COPD

A

FEV1/FVC < 0.70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the severity scale of COPD based on airflow limitation on spirometry

A
  • Mild: FEV1 >80%
  • Moderate: FEV1: 50-80%
  • Severe: FEV1: 30-50%
  • Very severe: FEV1 <30%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

List the management goals in COPD patients

A
  • Prevent disease progression
  • Reduce the frequency and severity of exacerbations
  • Alleviate breathlessness
  • Improve exercise tolerance and daily activity
  • Treat exacerbations and complications of disease
  • Improve health status
  • Reduce mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Describe the stepwise approach to pharmacological management of COPD according to CTS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What specific blood test should be done once in all patients diagnosed with COPD?

A

Alpha-1 antitrypsin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Describe the non-pharmacological management of COPD

A
  1. Smoking cessation + living in a smoke free environement
    1. Increases survival and improves rate of FEV1 decline
  2. Pulmonary rehab and remaining physically active
    1. Most effective therapy to improve dyspnea, exercise capacity and health status
    2. Reduces exacerbations if started following recent (<4 weeks) exacerbation
    3. Increased survival if started <4 weeks post exacerbation
  3. Supplemental O2 *
    1. ​Increased survival in severe resting hypoxemia
    2. No benefit in moderate resting or exercise induced moderate desaturation
    3. Offer to patients with severe hypoxemia (PaO2<55mmHg) or when PaO2 <60 and presence of bilateral ankle edema, cor pulmonale or HCT>56%
  4. vaccination
  5. self-management and education
  6. review of inhaler techniques
  7. end of life care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Describe the modified MRC dyspnea scale

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What inhaled therapy should be prescribed in COPD based on severity of disease and risk of exacerbation

A

*High risk of exacerbation is defined as 2 or more exacerbations in the past year or 1 or more requiring hospitalization

**LAMA preferred to ICS

No role for ICS monotherapy, increased infection risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What further escalation of therapy can be considered to prevent exacerbations in patients already on triple therapy

A

NAC can also be considered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What vaccines are indicated in the maintenance treatment of COPD?

A
  1. Influenza
  2. Pneumococcal
  3. TdAP pertussis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What is recommended for the symptomatic treatment of dyspnea in advanced COPD?

A
  1. Oral opioids (not nebulized)
  2. Neuromuscular electrical muscle stimulation
  3. Chest wall vibration
  4. walking aids
  5. pursed-lip breathing
  6. Continuous O2 therapy for hypoxemic COPD patients reduces mortality and may reduce dyspnea

not recommended

  1. Anxiolytics and antidepressants
  2. Supplemental o2 in non-hypoxemic patients

Not enough evidence

  1. Acupuncture
  2. acupressure
  3. destructive auditory stimuli
  4. relaxation
  5. handheld fans
  6. Counseling and support programs
  7. psychotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What are the diagnostic criteria for ACO

A
  • Required
    1. Diagnosis of COPD given risk factors, history, spirometry
    2. History of asthma (past Dx, current sx consistent or physiology confirmed with spirometry
    3. Spirometry: post-bronchodilator fixed FEV1/FVC <0.7
  • Supportive but not required
    1. Documentation of a bronchodilator improvement of FEV1 by 200ml or 12%
    2. sputum eosinophils >3%
    3. Blood eosinophils >300 cells/uL (current or previously documented)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

How is ACO treated

A
  • 1st line ICS-LABA
  • Refractory symptoms, add LAMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

How would you treat a COPD patient with severe chronic hypercapnia and a history of hospitalisations for hypercarbic resp failure

A

If pCO2>52, NIV. COnsult respirology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

In which patients should you consider lung reduction surgery

A

Severe emphysema with upper lobe predominant disease and low post-rehabilitation exercise capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What are the criteria for lung transplant in COPD patients

A
  • BODE score 7-10 and 1 of
    1. Hospitalized with COPDe with PCO2 >50
    2. Pulmonary hypertension/cor pulmonale despite supplemental oxygen
    3. FEV1<20 with DLCO<20
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

When should antibiotics be used in COPD exacerbation?

A
  1. Presence of 3 cardinal symptoms (2 if one of them is increased purulence)
    1. Increase in dyspnea
    2. Increase in sputum volume
    3. Increase in sputum purulence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

When antibiotics are indicated in COPD exacerbation, which ones should be used? And for how long

A
  • Depends on local resistance pattern, usually amox-clav, macrolide, tetracycline
  • treat 5-7 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What are the indications for steroid treatment in AECOPD

A
  • Moderate to severe exacerbations with 40mg Pred x 5 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

When should BIPAP be considered in COPD exacerbation

A
  • If any of:
    1. pH<7.35 or pCO2>45
    2. severe dyspnea (i.e. impending resp failure)
    3. persistent hypoxemia despite supplemental O2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What is the treatment for smoking cessation

A

Varencicline + nicotine patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What are the most common symptoms of bronchiectasis

A
  • Chronic resp. disease characterised by cough, sputum production and bronchial infectiom
    • Most common symptoms
      • Cough with sputum and/or hemoptysis
      • dyspnea and fatigue
      • rhinosinusitis
      • Thoracic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What are the treatment goals in bronchiectasis

A
  • Prevent exacerbations
  • improve QOL
  • reduce disease progression
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What are the etiologies of bronchiectasis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What should be the workup for bronchiectasis?

A
  1. ABPA testing
    1. CBC
    2. Total IgE
    3. Sensitization to aspergillus
  2. Serum immunoglobulins
  3. CF sweat test
  4. Test for primary ciliary dyskinesia (nasal nitric oxyde)
  5. Sputum cultures

Also consider

  • RF, Anti-CCP, ANA, ANCA
  • Alpha1 antitrypsin
  • HIV testing
  • Videofluoroscopic swallow study
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the treatment of chronic bronchiectasis

A
  1. Airway clearance
    1. Active cycle of breathing technique
  2. Mucoactive agents
    1. hypertonic saline
    2. DNAse only in CF
  3. Antimicrobials
    1. Inhaled colistin or gentamycin if Pseudomonas colonized
    2. Chronic azithromycin if recurrent exacerbations (with or without Pseudomonas colonization … rule out NTM)
  4. Bronchodilators
    1. Use if otherwise indicated
    2. Offer trial if significant breathlessness
  5. Pulmonary rehab
    1. If functionally limited by dyspnea (MRC≥1)
  6. Vaccines
    1. Influenza
    2. Pneumococcal
  7. Supplemental O2
    1. Same criteria as COPD
  8. No routine ICS, oral steroids, PDE4-I

Advanced therapies:

  1. Consider surgery, lung resection if localized disease
  2. Transplant if:
    1. Poor lung function plus 1 of:
      1. Massive. hemoptysis
      2. severe pulmonary hypertension
      3. ICU admissions
      4. resp failure requiring NIV
  3. NIV if resp failure + hypercarbia, especially if recurrent hospitalization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

How are bronchiectasis exacerbations treated

A
  1. Get sputum culture
  2. Use empiric antibiotics and target previously grown organisms
  3. 14 day course of ABx, especially if known Pseudomonas colonized
  4. IV ABx if unwell, admitted or resistant organisms. Or if failed oral therapies
66
Q

How is major hemoptysis managed in patients with bronchiectasis

A
  1. IV antimicrobials
  2. TXA
  3. Consider embolization
67
Q

Describe the categorization of ILD

A
68
Q

What exposures should you ask for on history in a patient with suspected ILD

A
  1. Organic (hypersensitivity pneumonitis)
    1. Mould/water damage
    2. Birds
    3. Farms
    4. Feather pillows
    5. hot tubs
  2. Inorganic (pneumoconiosis)
    1. Asbestos
    2. mining
    3. sandblasting
69
Q

What workup should be sent in all patients with suspected ILD

A
  1. Connective tissue disease workup
    1. ANA, RF, Anti-CCP in all
    2. Further workup if indicated
  2. HRCT chest
  3. PFTs +/- 6 minute walk test +/- home O2 assessment
  4. Precipitating antibodies for some known antigens for HP
  5. Resp and rheum referal
  6. Consider lung Bx (sometimes)
70
Q

Around what age do patients develop IPF

A

6th or 7th decade

71
Q

What is the radiological pattern seen in IPF

A

UIP

72
Q

What environmental exposure is linked to IPF

A

Smoking

73
Q

What are the required criteria for the diagnosis of IPF

A
  1. Exclusion of other known causes of ILD
  2. UIP pattern on HRCT
  3. histology pattern on Bx (if patient had biopsy, not required)
74
Q

What are the radiology patterns that fit with a description of UIP and which ones would suggest an alternate diagnosis?

A
75
Q

How is IPF treated

A
  1. Quit smoking
  2. O2 therapy if needed
  3. Pulmonary rehab
  4. PPI
  5. Pneumoxav and influenza vaccine
  6. antifibrotic medications
    1. Nintendanib
    2. pirfenidone

* no role for corticosteroids or immunosuppression

76
Q

What are the side effects of nintendanib

A
  1. Diarrhea
  2. GI upset
  3. transaminitis
77
Q

How is an acute exacerbation of IPF diagnosed

A

Worstening dyspnea and hypoxemia with diffuse bilateral ground glass on CT

78
Q

How are acute exacerbations of IPF treated?

A
  1. Rule out infection, HF, PE
  2. High dose corticosteroids (1g/day x3 -> 1mg/kg daily) and empiric antimicrobials

*Dismal prognosis 50% in hospital mortality

79
Q

Who should get supplemental O2 in IPF?

A
  • Restig hypoxemia – Same criteria as COPD
  • Exertionnal hypoxemia – (sat<88%) with improved walk distance or dyspnea on supplemental oxygen
80
Q

Name causes of hypersensitivity pneumonitis

A

Organic exposures (Moulds, birds)

81
Q

What are the imaging and lab findings in hypersensitivity pneumonitis

A

Upper lobe predominant

+ precipitating antibodies to antigen

82
Q

How is hypersensitivity pneumonitis treated

A

Antigen avoidance

steroids

Sometimes MMF or AZA

83
Q

What are causes of pneumoconiosos

A

Inorganic exposures years ago (asbestos, silica…)

84
Q

What can be found on imaging in pneumoconioses

A

Variety of different imaging findings

85
Q

How are pneumoconioses treated

A

Supportive care

transplant

86
Q

What causes CTD associated ILD

A
  1. Scleroderma
  2. RA
  3. Dermatomyositis
  4. Sjogren’s
  5. MCTD
87
Q

What are the imaging findings in CTD ass. ILD

A

Variety – NSIP, UIP, organizing pneumonias and others

88
Q

What is the treatment for CTD ass. ILDs

A

Treat the CTD

89
Q

What drugs cause drug induced ILD

A
  1. Methotrexate
  2. Amiodarone
  3. Nitrofurantoin
  4. Bleomycin
  5. Vaping
90
Q

How is drug induced ILD treated

A

Drug withdrawl and corticosteroids

91
Q

What are the indications to do a thoracentesis

A
  • Suspected exudate
  • cause unclear
  • Parapneumonic effusion, not if less than 1cm of fluid on lateral decubitus in context of pnoumonia

*Aspiration should NOT be performed for bilateral effusions in a clinical setting strongly suggestive of a transudate/CHF

92
Q

What are the light criteria

A
  1. Protein in fluid:serum >0.5
  2. LDH in fluid: serum >0.6
  3. Pleural fluid in LDH >2/3 ULN value for serum LDH
93
Q

In the setting of an exudate NYD, how can malignancy be ruled out?

A
  1. Repeat thoracentesis once for increased sensitivity
  2. CT chest
  3. Refer for pleural biopsy
    1. Thoracoscopy + pleural Bx is prefered test
    2. if obvious area of abnormality on CT, can proceed to CT guided Bx

Mesothelioma can usually not be diagnosed based on pleural fluid alone. Requires pleural Bx

94
Q

List the common, less common and rare causes of pleural transudates

A
  • Common
    1. CHF
    2. Cirrhosis
  • Less common
    1. Hypoalbuminemia
    2. Peritoneal dialysis
    3. Hypothyroidism
    4. Nephrotic syndrome
    5. Mitral stenosis
  • Rare causes
    1. Constrictive pericarditis
    2. Urinothorax
    3. Meigs Syndrome
95
Q

Name the common, less common and rare causes of pleural exudates

A
  • Common
    1. Malignancy
    2. Parapneumonic effusions
    3. Tb
  • Less common
    1. PE
    2. RA and other auto-immune pleuritis
    3. Benign asbestos effusion
    4. Pancreatitis
    5. Post-MI
    6. post-CABG
  • Rare causes
    1. Yellow nail syndrome
    2. Drugs
    3. Fungal infections
96
Q

What are the causes of a chylothorax

A
  1. Malignancy most common (lyphoma)
  2. Trauma/surgery
  3. Tb
  4. LAM
97
Q

What are the causes of pleural fluid eosinophilia?

A
  • Depends on history
    • Asbestos relate (BAPE)
    • Drugs (ex. Nitrofurantoin)
    • Malignancy (lung)
    • infection (parasites)
    • PE
    • eGPA
98
Q

What are causes of low glucose in a pleural effusion?

A

<1 RA, empyema

1-3, malignancy, Tb, SLE

99
Q

What are causes of increased lymphocytes in pleural fluid?

A

>80% are Tb or lymphoma

Other DDx: Carcinoma, yellow nail, sarcoidosis, RA

100
Q

What are the indications to insert a chest tube?

A
  1. Drainage of cloudy pleural fluid or frank pus
  2. Positive gram stain or culture
  3. pH<7.2 (or glucose <3.4)
  4. >50% of hemithorax or loculation on imaging
101
Q

How should an empyema be treated empirically. For how long

A

Based on gram stain if available

If not Cover CAP + anaerobes

Requires prolonged ABx course. Usually 3 weeks

102
Q

What are the risk factors for primary spontaneous pneumothorax

A
  1. Smoking
  2. Family history
  3. Marfan
  4. Thoracic endometriosis
103
Q

How are primary spontaneous pneumpothoraces treated

A
  • If < 2cm with minimal signs and symptoms, monitor
  • If >2cm or with signs. and symptoms: needle aspiration +/- chest tube insertion.
    • Surgery if persistent leak
104
Q

What are the risk factors for secondary spontaneous pneumothorax

A
  1. COPD
  2. Tb
  3. CF
  4. PCP
105
Q

How are secondary spontaneous pneumothoraces managed

A
  1. As they are more likely to lead to significant symptoms, most are drained. Often require admission
  2. More likely to require chest drain
106
Q

In sarcoidosis, which organ involvement requries urgent treatment

A
  1. Heart
  2. CNS
  3. Eyes
107
Q

What other organs, other than lungs, can be involved in sarcoid

A
  1. Heart
  2. CNS
  3. eyes
  4. liver
  5. spleen
  6. MSK
  7. kidneys
108
Q

Describe Lofgren’s syndrome

A
  1. Bilateral Hilar lymphadenopathy
  2. Erythema nodosum
  3. Migratory polyarthralgias
  4. Fever

*Primarily seen in women

*High likelyhood of spontaneous remission

109
Q

Describe Heerfordt’s syndrome

A
  1. Anterior uveitis
  2. Parotid enlargement
  3. Facial palsy
  4. Fever
110
Q

What are the stages of sarcoid?

A
111
Q

Describe the clinical findings of cutaneous sarcoid

A
  1. Lupus pernio
  2. erythema nodosum
  3. Others…
112
Q

Describe the findings of liver and spleen sarcoid

A
  1. Elevated LFTs
  2. Cholestasis
  3. Rarely liver failure
113
Q

What are the neurological findings of Sarcoid

A
  1. Cranial nerve palsy
  2. headache
  3. Ataxia
  4. Weakness
  5. Non-specific lymphocytic infiltration on LP
114
Q

What are the occular findings of sarcoid

A

Anterior uveitis

115
Q

What are the cardiac findings of sarcoid

A
  1. Cardiomyopathy
  2. Heart block
  3. arrythmias
116
Q

What electrolyte is elevated in sarcoidosis

A

Hypercalcemia

117
Q

What investigations should be done to confirm a diagnosis of Sarcoidosis

A
  1. CXR +/- CT
  2. PFTs
  3. Biopsy (tissue or EBUS)
  4. CBC: Anemia of chronic disease, lymphopenia, thrombocytopenia
  5. LBC: Hypercalcemia, Cr
  6. Albumin
  7. LFTs
  8. ECG
    1. If suspecting cardiac involvement do cardiac MRI (ideally) or PET scan
    2. Echo if suspecting pulmonary hypertension
  9. Ophtalmology referral, r/o occular sarcoid
  10. Bronchoscopy/BAL: Low CD4, elevated CD4/CD8 ratio
  11. 24 hour urine, screen for hypercalciuria

*Serum ACE level not necessary. 70% sensitive 90% specific for active disease

118
Q

What are the indications for treatment in sarcoidosis

A
  • Pulmonary sarcoid
    1. Bothersome symptoms (cough and dyspnea)
    2. Deteriorating lung function as measured by PFTs
    3. Developpement of pulmonary hypertension
  • Extrapulmonary sarcoid
    1. Eye, CNS, cardiac involvement
    2. Severe skin disease, hypercalcemia, symptomatic liver disease

*Most patients do not require treatment. Steroids make the disease remit faster but increase the risk of recurrence.

119
Q

How is sarcoidosis treated

A
  • Mild respiratory symptoms (cough and stable PFTs)
    • Treat with inhaled steroids
  • Erythema nodosum
    • Usually responds to NSAIDs alone
  • Almost anything else:
    • Treat with prednisone 20-40mg daily
    • Usually, treat for 1-3 months at initial dose then slowly taper to 10mg daily. With treatment continued for 1 year
    • In the case of relapse, can consider MTX (or less commonly HCQ, LEF, TNF alpha inhibitors)
  • MTX can also be used if continued disease despite prednisone or toxicity from steroids
  • Pulmonary rehab is first-line for sarcoidosis related fatigue
120
Q

How is pulmonary hypertension defined?

A

Mean pulmonary artery pressure >20mmHg and pulmonary vascular resistance >3WU on right heart catheterisation

121
Q

How does pulmonary hypertension present?

A
  1. Slowly progressive dyspnea on exertion
  2. Eventually right heart failure
  3. Isolated reduced DLCO
122
Q

What workup should be done when suspecting pulmonary hypertension

A
  1. Echocardiogram:
    1. Assess right heart function
  2. CBC, LBC, LFTs, TSH, BNP
  3. PFTs
  4. 6MWT
  5. VQ scan
  6. CTD serologies
  7. Sleep study if concerns for OSA
  8. HIV
  9. Confirm diagnosis on right heart cath
123
Q

Describe the 5 WHO groups of pulmonary hypertension

A
  • Group 1: PAH
    • Idiopathic, heritable, drug/toxin induced
    • Associated with CTD, HIV, portal HTN, schistosomiasis
  • Group 2: 2/2 left heart disease
    • Systolic or diastolic dysfunction
  • Group 3: 2/2 lung disease/ hypoxemia
    • COPD/ILD etc…
  • Group 4: CTEPH
  • Group 5: Others
    • 2/2 heme disorders (MPN, splenectomy)
    • 2/2 systemic disorders (sarcoid, LCH, LAM)
124
Q

How is group 1 pulmonary hypertension treated?

A
  • Vasoreactive testing to determine if candidate for CCB
  • PDE5 inhibitor or riociguat
  • endothelin receptor antagonist
  • prostanoid
  • Influenza/pneumococcal vaccine
125
Q

How is group 2 pulmonary hypertension treated?

A

Treat the heart failure

126
Q

How is group 3 pulmonary hypertension treated?

A

Treat the underlying cause

127
Q

How is group 4 pulmonary hypertension treated?

A
  • Refer for pulmonary endarcterectomy
  • trial of anticoagulation
128
Q

How is group 5 pulmonary hypertension treated?

A

Treat the underlying cause

129
Q

How should patients with scleroderma be screened for PH?

A

Yearly echo and DLCO

130
Q

When should patient with portal hypertension be screened for pulmonary hypertension

A

During transplant workup

131
Q

When should patients be screened for CTEPH after an acute PE

A

If they are still short of breath after 3 months of therapeutic anticoagulation

132
Q

How is the A-a gradient calculated and what is the normal value?

A

Aa=150-PaCO2/0.8

Normal =(age/4)+4

133
Q

Name causes of hypoxemia with a normal A-a gradient

A
  • Hypoventilation
    • CNS depression
    • Spinal cord injury
    • Chest wall abnormality
    • diaphragm dysfunction
    • neuromuscular disorder
    • OHS
  • Low inspired FiO2
134
Q

Name causes of hypoxemia with a widened A-a Gradient

A
  1. V/Q mismatch
    1. COPD, PE
    2. Improves with 100% FiO2
  2. Shunt
    1. Does not completely improve with 100% FiO2
    2. Intracardiac, intrapulmonary, physiologic
  3. Diffusion abnormality
    1. ILD
135
Q

What are the criteria for home O2 (in Ontario)

A
  • PaO2 <55
  • Sat <88%
  • PaO2 55-59 with:
    • Cor pulmonale
    • Pulmonary hypertension
    • persistent erythrocytosis
136
Q

List the differential diagnosis for hemoptysis

A
  1. Infectious
    1. Bronchiectasis
    2. Bronchitis
    3. Tb
  2. Neoplastic
    1. Carcinoid
      1. Young non-smoker with lung collapse
    2. Malignant
      1. NSCLC or SCLC
    3. CTD
      1. Anti-GBM
      2. GPA (or other vasculitis)
      3. SLE
    4. Drugs/toxins
      1. Cocaine
      2. Anticoagulation
    5. Vascular
      1. Pulmonary AVM
      2. Bronchial artery aneurysm
      3. PE
137
Q

How is massive hemoptysis managed?

A
  1. ENsure ABCs
  2. Decubitus position
  3. Hold anticoagulation, correct coagulopathy
  4. Image if patient is stable enough
    1. CXR/CT
    2. bronch
  5. Arterial embolization in IR is ideal
    1. If not available, then consider rigid bronchoscopy or resection (thoracic surgery)
138
Q

What are the criteria for pulmonary rehab in long COVID?

A

New/Ongoing respiratory symptoms and functional limitations after resolution of acute COVID 19

AND

New or ongoing requirements for supplemental O2

OR at least 1 of

  • Persistent radiographic pulmonary abnormalities
  • PFTs showing new/persistent reduction in lung volumes, airflow limitations and/or decreased DLCO
139
Q

Give a differential diagnosis for cough

A
140
Q

Give an approach to chronic cough

A
  1. Exclude ACEi
  2. CXR
  3. Then test for these conditions in this order:
    1. Upper airway cough syndrome
      1. Give antihistamines/decongestionant and assess for response
      2. Sinus imaging if no improvement
    2. Asthma
      1. Methacholine challenge or empiric ICS
    3. Non-asthmatic eosinophilic bronchitis
      1. Sputum eosinophils or empiric trial of corticosteroids
    4. GERD
      1. if “clinic profile”. fits, treat. empirically
        1. Lifestyle modifications: coffee, chocolate, etc…
        2. H2RA/PPI
        3. Prokinetic
      2. 24hrs pH monitoring on therapy if cough persists
      3. If refractory, antireflux surgery
141
Q

What is the physical exam finding with the highest +LR for sleep apnea?

A

Nocturnal gasping /choking

142
Q

How is sleep apnea diagnosed and what are the severity criteras?

A
  • Sleep study
    • Diagnosis: >5 apnea/hypopnea events/hr
    • Mild: 5-15 events/hr
    • Moderate: 15-30 events
    • severe >30 events
143
Q

What are the indications to treat sleep apnea?

A
  1. Sx of excessive sleepieness or impaired sleep related QOL
  2. Comorbid HTN
  3. Asymptomatic patients with severe OSA
  4. Critical occupation
144
Q

Wow is sleep apnea treated

A
  1. Weight loss
  2. CPAP
  3. Oral appliances – for mild-moderate disease
  4. Surgery (rarely)
    1. Tonsillectomy if appropriate
    2. uvulopalatopharyngoplasty in select patients
145
Q

What are the driving restrictions in OSA?

A

Severity of OSA alone does not disqualify a person from driving

  • Patients should not drive if:
    1. The driver admits to experiencing excessive sleepiness during the major wake period while driving
    2. The driver experienced a crash associated with falling asleep in the past 5 years if effective therapy has not been instituted in the interim
    3. The driver is non-compliant with treatment
146
Q

What are the guidelines for follow-up of solid pulmonary nodules?

A
147
Q

What are the guidelines for follow-up imaging in sub-solid pulmonary nodules?

A
148
Q

What are the criteria for lung transplant in COPD?

A
  • FEV1 ≤25% +/- PaCO2 ≥55
  • Severe disease, resting hypoxemia <55mmHg
149
Q

What are the indications for lung transplant in CF

A

FEV1 <30% +/- PaCO2 >50

150
Q

What are the indications for transplant in IPF/ILD

A
  • Symptomatic
  • FVC < 60-65%
151
Q

What are the indications for lung transplant in pHTN

A

Pulmonary HTN class III or IV or severe

152
Q

What is the differential diagnosis for clubbing

A
  1. Neoplastic intrathoracic disease
    1. Bronchogenic carcinoma
    2. mesothelioma
  2. Suppartive intrathoracic diseases
    1. Lung abcess
    2. Empyema
    3. Bronchiectasis
    4. CF
  3. Diffuse pulmonary disease
    1. Pulmonary fibrosis
  4. Cardiac disease
    1. Cyanotic CHD
    2. IE
  5. GI diseases
    1. IBD
  6. Metabolic diseases
    1. Graves
153
Q

What are the contraindications to PFTs?

A
  • Hemoptysis
  • Pneumothorax
  • Unstable cardiovascular status including recent MI
  • Aneurysms
    • Thoracic abdominal or cerebral
  • Recent eye surgery
  • Recent thoracic or abdominal surgery
  • Presence of acute illness that may interfere with test performance
154
Q

What are the contraindications to a methacholine challenge?

A
  • Absolute
    1. Severe airflow limitation: FEV1<50% or <1L
    2. MI or stroke in last 3 months
    3. Uncontrolled HTN: BP 200/100
    4. Known aortic aneurysm
  • Relative
    1. Moderate airflow limitation: FEV1<60% or 1.5L
    2. Pregnancy or nursing mothers
    3. Use of cholinesterase inhibitor
155
Q

What can cause an isolated decrease in DLCO

A
  1. pulmonary hypertension
  2. Early ILD or emphysema
  3. Anemia
156
Q

What can cause an increase in DLCO?

A
  1. Pulmonary hemorrhage
  2. polycytemia
  3. L heart failure
157
Q

What causes a restrictive pattern of PFTs which varies with position

A

Diaphragm dysfunction

158
Q

Name predictors of adverse perioperative pulmonary events

A
  1. Most important: Site of surgery
    1. aortic>intrathoracic>upper abdo>abdominal
  2. Age
  3. Lung disease
159
Q

What is the role of pre-op PFTs and perfusions scans

A

Calculation of post-op FEV1 and DLCO

160
Q

What can cause diaphragmatic weakness?

A
  1. Idiopathic
  2. Trauma or surgery (C3,4,5)
  3. Mechanical ventilation
  4. Myopathy, neuropathy
    1. ALS
    2. MG
    3. Critical illness myopathy/neuropathy
161
Q

What is the most sensitive and the most specific test to rule out diaphragmatic weakness

A

Most sensitive=MIP

Most specific: Not clear. try US. On PFTs probably FVC

RCPSC (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions